Stanford Graduate School of Business (USA)
-
Invitrogen (A)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209A-EStrategyFounded in 1987, Invitrogen was one of the largest catalog life science companies in the industry. Its customers came from academic research, biotechnology and pharmaceutical companies and government laboratories. Scientists viewed Invitrogen as a one-stop shop for all major molecular biology, biochemistry and cell culture reagent products, with prices ranging from a hundred dollars to a few thousand dollars.Starting at €8.20
-
Invitrogen/Life Technologies (B)
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209B-EStrategyOn June 12, 2008, Invitrogen and Applied Biosystems announced plans to merge. The combined company was to be renamed Life Technologies (NASDAQ: LIFE). Invitrogen offered to acquire Applied Biosystems for $6.7 billion in cash and stock. AB shareholders would receive $38 per share in cash and stock, representing a 17 percent premium over the share’s closing price on Wednesday, June 11, 2008.Starting at €5.74
-
Crocs (A): Revolutionizing and Industry's Supply Chain Model for Competitive Advantage
Holloway, C; , Lee, H; , Hoyt, D; , Silverman, A; , Marks, MCase SGSB-GS57A-EService and Operations ManagementEste caso analiza el crecimiento asombroso de Crocs, Inc., un fabricante de zapatos de plástico, desde 2003 hasta principios de 2007. Gran parte del crecimiento de la empresa fue posible gracias a una cadena de suministro altamente flexible que permitió a Crocs desarrollar productos adicionales dentro de la temporada de ventas. El modelo habitual en la industria de la moda era recibir órdenes mucho antes de cada temporada de ventas, y producir es...Starting at €8.20
-
Crocs: Revolutionizing and Industry's Supply Chain Model for Competitive Advantage - Teaching Note
Holloway, C; , Lee, H; , Hoyt, D; , Silverman, A; , Marks, MTeaching Note SGSB-GS57TN-EService and Operations ManagementThis case discusses the astounding growth of Crocs, Inc., a manufacturer of plastic shoes, from 2003 through early 2007. Much of the company’s growth was made possible by a highly flexible supply chain which enabled Crocs to build additional product within the selling season. The normal model used within the fashion industry was to take orders well in advance of each selling season, and produce to those orders, with relatively little additional...Starting at €0.00
-
Invitrogen/Life Technologies (C): The "Best Owner" of the Asset
Burgelman, R; Siegel, R; Lee, RCase SGSB-SM209C-EStrategyThis short case discusses the process of Life Technologies’ acquisition by Thermo Fisher in 2013 and 2014. The case is a complement to SM-209A and SM-209B, which highlight the various growth and acquisition strategies the company undertook over the previous 10 years.Starting at €5.74